Valuation: Zoetis Inc.

Capitalization 51.85B 44.17B 41.26B 38.82B 71.47B 4,696B 78.08B 482B 187B 2,214B 195B 190B 8,077B P/E ratio 2025 *
19.6x
P/E ratio 2026 * 18.3x
Enterprise value 56.54B 48.17B 45B 42.34B 77.94B 5,121B 85.15B 525B 204B 2,414B 212B 208B 8,808B EV / Sales 2025 *
5.99x
EV / Sales 2026 * 5.64x
Free-Float
88.45%
Yield 2025 *
1.68%
Yield 2026 * 1.88%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.08%
1 week+0.03%
Current month-7.40%
1 month-2.11%
3 months-19.91%
6 months-29.69%
Current year-27.15%
More quotes
1 week 115.59
Extreme 115.59
121.08
1 month 115.25
Extreme 115.25
129.58
Current year 115.25
Extreme 115.25
177.4
1 year 115.25
Extreme 115.25
181.85
3 years 115.25
Extreme 115.25
201.92
5 years 115.25
Extreme 115.25
249.27
10 years 38.26
Extreme 38.26
249.27
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2020
Director of Finance/CFO 53 01/06/2021
Chief Operating Officer 52 01/08/2024
Director TitleAgeSince
Chairman 67 01/07/2012
Director/Board Member 67 01/01/2013
Chairman 72 26/06/2013
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.06%+0.03%-33.63%-22.35% 51.85B
+0.24%-2.69%+69.26%+68.59% 10.57B
+0.11%-1.34%-21.21%-1.45% 3.36B
-0.44%-4.91%+4.79%+37.53% 3.35B
+6.73%+20.77%+113.03%+72.15% 2.28B
-1.69%+2.32%+67.80%+212.56% 1.65B
+2.63%-4.63%-29.66%-16.55% 1.6B
+1.26%-0.05%-5.50%-6.69% 1.22B
-1.39%-1.52%+5.83%-36.38% 1.14B
-0.26%+2.67%0.00%-8.98% 1.07B
Average +0.90%-0.69%+17.07%+29.84% 7.81B
Weighted average by Cap. +0.96%-2.08%-9.54%+1.49%
See all sector performances

Financials

2025 *2026 *
Net sales 9.44B 8.04B 7.51B 7.07B 13.01B 855B 14.22B 87.69B 34.01B 403B 35.42B 34.68B 1,471B 9.93B 8.46B 7.9B 7.44B 13.69B 900B 14.96B 92.24B 35.78B 424B 37.26B 36.48B 1,547B
Net income 2.68B 2.29B 2.14B 2.01B 3.7B 243B 4.04B 24.93B 9.67B 115B 10.07B 9.86B 418B 2.83B 2.41B 2.25B 2.12B 3.9B 256B 4.26B 26.28B 10.19B 121B 10.62B 10.39B 441B
Net Debt 4.69B 4B 3.73B 3.51B 6.47B 425B 7.07B 43.58B 16.91B 200B 17.61B 17.24B 731B 4.15B 3.53B 3.3B 3.1B 5.71B 375B 6.24B 38.5B 14.94B 177B 15.55B 15.23B 646B
More financial data * Estimated data
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
13,800
More about the company
Date Price Change Volume
12/12/25 118.70 $ +0.88% 2,890,729
11/12/25 117.66 $ -0.35% 6,150,114
10/12/25 118.07 $ +2.00% 5,915,846
09/12/25 115.75 $ -2.04% 4,364,448
08/12/25 118.16 $ -0.41% 5,272,577

Delayed Quote Nyse, December 12, 2025 at 09:53 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
117.66USD
Average target price
161.03USD
Spread / Average Target
+36.86%
Consensus

Quarterly revenue - Rate of surprise